Medullary Thyroid Cancer (MTC) Terminated Phase 2 Trials for Sorafenib (DB00398)

Also known as: Thyroid Cancer, Medullary / Medullary Thyroid Carcinoma / Medullary Thyroid Cancer / Parafollicular cell carcinoma (disorder) / Medullary carcinoma with amyloid stroma (morphologic abnormality) / Medullary carcinoma (morphologic abnormality) / Medullary thyroid carcinoma (disorder) / Medullary carcinoma of thyroid

IndicationStatusPhase
DBCOND0062236 (Medullary Thyroid Cancer (MTC))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03630120Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid CancerTreatment